MEDICAL ADVOCATES
WOMEN AND HIV RESOURCE CENTER
  Obstetrical Risks/Strategies
General Reports
 Abortion
Membrane Status
Placenta
 Mode of Delivery
Intrapartum Fetal Invasive Procedures 
 



 
HIV Pregnancy Main Page Women Main Page  

Last Update:  February 28, 2015     
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
 

          Journal Papers, Abstracts, and Commentaries

 

A WEEK-IN-REVIEW FEATURED REPORT
 Antiretroviral therapy and preterm birth in HIV-infected women.
 Short CE, Taylor GP. Expert Rev
Anti Infect Ther. 2014 Feb 6.
 Abstract

FULL-TEXT ARTICLE
 HIV and the Risk of Direct Obstetric Complications: A Systematic Review and Meta-Analysis.
 Calvert C, Ronsmans C.
PLoS One. 2013 Oct 4;8(10):e74848.
 Paper

Premature Delivery in HIV-Infected Women Starting Protease Inhibitor Therapy During Pregnancy:
Role of the Ritonavir Boost?
Sibiude J, Warszawski J, Tubiana R, et al 
Clin Infect Dis. 2012 Mar 28.
 Abstract

Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States
and Europe.
 Townsend C, Schulte J, Thorne C,  et al
BJOG. 2010 Aug 17
 Abstract

Transplacental haemorrhage may explain the intrapartum transmission of HIV. A pilot study uses
flow cytometry to quantify maternal red blood cells in infants born vaginally or by caesarean section.
De Vries BS, Cossart YE, Murray H, Peek MJ.
 Aust N Z J Obstet Gynaecol. 2008 Dec;48(6):575-9
 Abstract
 
A WEEK IN REVIEW FEATURED REPORT
Anesthesia for the Pregnant HIV Patient.
 Hignett R, Fernando R. 
Anesthesiol Clin. 2008 Mar;26(1):127-43
 Abstract
 
Increased Rates of Preterm Delivery Are Associated with the Initiation of Highly Active
Antiretroviral Therapy during Pregnancy: A Single-Center Cohort Study.
 Martin F, Taylor GP.
 J Infect Dis. 2007 Aug 15;196(4):558-61
 Abstract
 
Higher Rates of Post-partum Complications in HIV-Infected Than in
-Uninfected Women Irrespective of Mode of Delivery: European HIV in Obstetrics Group.
European HIV in Obstetrics Group.  
Obstet Gynecol Surv. 2004 Nov;59(11):761-763.
 Abstract
 
Anesthetic Considerations for the HIV-Infected Pregnant Patient.
Kuczkowski KM.
Yonsei Med J. 2004 Feb 29;45(1):1-6
 Abstract
 
Human Immunodeficiency Virus: Anesthetic and Obstetric Considerations.
Evron S, Glezerman M, Harow E, et al.
Anesth Analg. 2004 Feb; 98(2): 503-511.
Abstract

Obstetrical factors and the transmission of human immunodeficiency virus type
1 from mother to child.
Landesman SH, Kalish LA, Burns DN,et al.,
N Eng J Med, 1996. 334: p. 1617-1623.  
Abstract
   
  Obstetric factors and mother-to-child transmission of human immunodeficiency
virus type 1: The French Perinatal Cohorts.
French Pediatric HIV Infection Study Group. Mandelbrot L, et al.,
Am J Obstet Gynecol, 1996. 175: p. 661-667.
Abstract
   
  Vertical transmission of HIV-1: maternal immune status and obstetric factors.
The European Collaborative Study. Newell ML, Dunn DT, Peckham CS et al
AIDS 1996 Dec;10(14):1675-81
Abstract

          Conference Reports, Abstracts and Posters

 

PDF POSTER
 Live births of HIV+ mothers. Are they different from others? A study from Rio de J
aneiro City, Brazil, 1999 – 2001.
Saraceni V, Rapparini C, Cruz M, et al.
(2nd IAS Conference)
Poster
   
  Risk Factors for Adverse Pregnancy Outcomes (APO) in HIV-Infected Pregnant
Women in PACTG 185.
(6RETRO)
Abstract
Abortion
 

          Journal Papers, Abstracts, and Commentaries

  Bolstering the Evidence Base for Integrating Abortion and HIV Care: A Literature Review.
 Manski R, Dennis A, Blanchard K, et al.
 AIDS Res Treat. 2012;2012:802389.
Abstract

Morbidity that is associated with curettage for the management of
spontaneous and induced abortion in women who are infected with HIV.
Stuart GS, Sheffield JS, Hill JB, et al  
Am J Obstet Gynecol. 2004 Sep;191(3):993-7.
 Abstract
 

Post-abortion endometritis-myometritis and HIV infection.
Okong P, Biryahwaho B, Bergstrom S.
Int J STD AIDS. 2002 Nov;13(11):729-32
 Abstract
Membrane Status
 

          Journal Papers, Abstracts, and Commentaries

  Duration of ruptured membranes and extended labor are risk factors for HIV transmission.
Garcia-Tejedor A, Perales A, Maiques V.
Int J Gynaecol Obstet. 2003 Jul;82(1):17-23.
Abstract
   
  Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from
15 prospective cohort studies.
International Perinatal HIV Group.
AIDS. 2001 Feb 16;15(3):357-68.
 Abstract
   
  The relationship of the duration of ruptured membranes to vertical transmission
of human immunodeficiency virus.
Minkoff H, Burns DN, Landesman S, 
Am J Obstet Gynecol 1995 Aug;173(2):585-9
Abstract
Placenta
 

           Journal Papers, Abstracts, and Commentaries

  FULL-TEXT ARTICLE
Up-regulation of CCR5 expression in the placenta is associated with human
immunodeficiency virus-1 vertical transmission.
Behbahani H, Popek E, Garcia P, et al.
Am J Pathol 2000 Dec;157(6):1811-8 
Paper
 
  Placental abnormalities associated with human immunodeficiency virus type 1
infection and perinatal transmission in bangkok, thailand.
Schwartz DA, Sungkarat S, Shaffer N, et al.
J Infect Dis 2000 Dec;182(6):1652-7 
Abstract
 
  Role of the placenta in fetal HIV infection.
Miller RK, Polliotti BM, Laughlin T, et al.
Teratology 2000 May;61(5):391-4 
Abstract
 
Human immunodeficiency virus infection: in situ polymerase chain reaction localization in
human placentas after in utero and in vitro infection.
Sheikh AU, Polliotti BM, Miller RK
Am J Obstet Gynecol 2000 Jan;182(1 Pt 1):207-13 
Abstract
 
Placental membrane inflammation and risks of maternal-to-child
transmission of HIV-1 in Uganda.
Wabwire-Mangen F, Gray RH, Mmiro FA, et al.
J Acquir Immune Defic Syndr 1999 Dec 1;22(4):379-85 
Abstract
 
Genetic analysis reveals ongoing HIV type 1 evolution in infected human
placental trophoblast.
Zachar V, Zacharova V, Fink T, Thomas RA, et al.
AIDS Res Hum Retroviruses 1999 Dec 
Abstract
 
FULL-TEXT ARTICLE
The trophoblastic epithelial barrier is not infected in full-term placentae of human
immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy.
Tscherning-Casper C, Papadogiannakis N, Anvret M, et al.
J Virol 1999 Nov;73(11):9673-8  
Paper
 
Response of fetal macrophages in the placenta of pregnant HIV-positive patients
with and without antiretroviral treatment.
Villegas Castrejon H, Mayon Gonzalez J, et al
Ginecol Obstet Mex 1999 May;67:196-206 
Abstract
 
Selection of maternal human immunodeficiency virus type 1 variants in human
placenta. European Network for In Utero Transmission of HIV-1.
Menu E, Mbopi-Keou FX, Lagaye S, et al,
J Infect Dis 1999 Jan;179(1):44-51  
Abstract
Intrapartum Fetal Invasive Procedures
 

          Journal Papers, Abstracts, and Commentaries

  Intrapartum fetal invasive procedures and perinatal transmission of HIV.
Maiques V, Garcia-Tejedor A, Perales A, Navarro C
 Eur J Obstet Gynecol Reprod Biol 1999 Nov;87(1):63-7
Abstract
   
  Is the risk of perinatal transmission of human immunodeficiency virus increased
by the intrapartum use of spiral electrodes or fetal scalp pH sampling?
Viscarello RR, Copperman AB, DeGennaro NJ
Am J Obstet Gynecol 1994 Mar;170(3):740-3  
Abstract

 

HIV Pregnancy Main Page Women Main Page  

HIV Obstetrical Risks/Strategies